In This Section

Research Funding Impact

Since 1993, the AACR has awarded more than $540 million in grants to fund meritorious research projects across the spectrum of cancer science, including basic, translational, and clinical research. See how the AACR grants program has contributed to the AACR's mission.

Loading...
AACR-PanCAN Pathway to Leadership Grant Helps Launch Scientists’ Independent Careers in Pancreatic Cancer Research

AACR-PanCAN Pathway to Leadership Grant Helps Launch Scientists’ Independent Careers in Pancreatic Cancer Research

Dedicated to accelerating the conquest of cancer, the AACR is a unique organization committed to funding research projects across all cancer sites and researchers at all career levels. In partnership with the Pancreatic Cancer Action Network (PanCAN), a nationwide organization dedicated to pancreatic cancer, the AACR-PanCAN Pathway to Leadership Grant was established in 2010. Running until 2017, the joint program offered $600,000 over five years to facilitate the career transition of pancreatic cancer researchers from postdoctoral/clinical research fellow to independent faculty.

AACR-Novocure grantee elucidates the impact of Tumor Treating Fields on the blood-brain barrier

AACR-Novocure grantee elucidates the impact of Tumor Treating Fields on the blood-brain barrier

Treatment options for brain cancers, including aggressive glioblastoma, are limited despite the availability of several chemotherapeutic drugs due to the inability of these drugs to cross the blood-brain barrier (BBB). AACR-Novocure grantee Dr. Carsten Hagemann and his team showed that the use of low-intensity alternating electric fields known as Tumor Treating Fields (TTFields), an FDA-approved treatment modality, can facilitate drugs crossing the BBB. Using multiple models, they elucidated the mechanisms driving this action.

AACR Grantees Share their Findings

AACR Grantees Share their Findings

We are extremely proud of our past and present grantees who published their findings this past year on their work that has been made possible through the support of the AACR and its funding partners.

Dr. Escobar-Hoyos Leverages Her AACR Grant

Dr. Escobar-Hoyos Leverages Her AACR Grant

Recipient of a 2021 AACR Career Development Award to Further Diversity, Equity, and Inclusion in Pancreatic Cancer Research, Luisa Escobar-Hoyos, PhD, shares how the AACR grant has been a critical step in her quest for federal funding for her more unconventional approach to treat pancreatic cancer.

Dr. Rosa Hwang shares the important contribution of the AACR-Bayer Innovation and Discovery Grant on her road to develop novel treatment strategies

Dr. Rosa Hwang shares the important contribution of the AACR-Bayer Innovation and Discovery Grant on her road to develop novel treatment strategies

The AACR-Bayer Innovation and Discovery Grants sought to uncover new treatment options for cancers with high unmet medical need and encourage translation of ideas from basic research into novel drugs. Surgical oncologist, Rosa Hwang, MD, received the grant in 2016, helping her pursue a new therapeutic target in pancreatic cancer.

Dr. Fariba Behbod shares how AACR grant support impacted her research on DCIS

Dr. Fariba Behbod shares how AACR grant support impacted her research on DCIS

AACR Special Conference “Rethinking DCIS: An Opportunity for Prevention” Plenary Session Speaker Fariba Behbod, Pharm D, PhD, received the AACR-Breast Cancer Research Foundation for Translational Breast Cancer Research award in 2014, when she was an Assistant Professor at the Kansas University Medical Center Research Institute. Now a Full Professor, she speaks on the impact of the AACR grant on her research and career.